Series C - Elixir Pharmaceuticals - Nov 27, 2006 Funding Round Profile - Cointime

Bitcoin $97,719.26 +0.19%
Ethereum $3,292.78 -1.71%
BNB $621.47 -0.48%
Optimism $2.16 +3.61%
Arbitrum $0.79 -1.26%
Solana $255.17 +3.97%
Polygon $0.45 +0.06%
Cosmos $6.89 +6.98%
Avalanche $38.19 +7.34%

Bitcoin $97,719.26 +0.19%
Ethereum $3,292.78 -1.71%
BNB $621.47 -0.48%
Optimism $2.16 +3.61%
Arbitrum $0.79 -1.26%
Solana $255.17 +3.97%
Polygon $0.45 +0.06%
Cosmos $6.89 +6.98%
Avalanche $38.19 +7.34%

Elixir Pharmaceuticals

company

Funding Round

Series C

Money Raised

$ 31M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Hercules Capital	-	-	-	Detail
ARCH Venture Partners	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Oct 13, 2003	Series B	$ 40.50M	ARCH Venture Partners	Detail